Requests that the FDA adhere to the statutory and regulatory procedures and processes governing advisory committees under 21 C.F.R. S 14 and FACA to allow for industry and all other stakeholders to comment on current and upcoming regulatory policies and procedures that FDA is discussing during the agency’s advisory committee expert panels. | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

Open for Comments

FDA-2026-P-3105

Requests that the FDA adhere to the statutory and regulatory procedures and processes governing advisory committees under 21 C.F.R. S 14 and FACA to allow for industry and all other stakeholders to comment on current and upcoming regulatory policies and procedures that FDA is discussing during the agency’s advisory committee expert panels.

Documents

Comments

Description

OPEN

Key Dates

Comment Period OpensMar 25, 2026

Documents

Type	Title	Posted	Comments	Status
Other	Acknowledgment Letter from FDA DMB to National Association of Manufacturers	Mar 25, 2026	--

Keywords

Citizen Petition

adhere to the statutory and regulatory

procedures and processes governing

advisory committees under 21 C.F.R. S 14

and FACA to allow for industry and

all other stakeholders to comment on

current and upcoming regulatory policies and

Data from Regulations.gov